Colorado Lawmakers Pass 340B Anti-discrimination Bill

Colorado state capitol building
Colorado lawmakers voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

The Colorado General Assembly has voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

Gov. Jared Polis (D) is expected to sign the bill, HB22-1122. He

Read More »

340B Providers Lose their Biggest GOP Ally in U.S. House

U.S. Rep. David McKinley (R-WA) gestures during hearing
U.S. Rep. David McKinley (R-W.Va.) lost his GOP primary election this week. It's a huge blow for 340B entities that have relied on his help in Congress for years.

In a major blow to the 340B provider community, U.S. Rep. David McKinley, the leading voice for the 340B program in the House Republican caucus, was defeated Tuesday in the West Virginia Republican primary. McKinley will remain in office until

Read More »

Drug Makers Ask Michigan Lawmakers to Erase Section from New 340B State Law

Copy of State of Michigan bill no. 4351
Michigan 340B hospitals say drug manufacturers are lobbying state lawmakers to erase language from a new state law that the hospitals say stops the drug makers from imposing claims submission requirements as a condition for 340B pricing.

Drug manufacturers are asking Michigan state legislators to erase language in a new state law that Michigan hospitals say bars the companies from withholding 340B pricing if a covered entity refuses to hand over its contract pharmacy claims data, 340B

Read More »

Sen. Grassley Presses HHS OIG to Punish Drug Makers Over Denials of 340B Pricing

Sen. Chuck Grassley (R-IA) headshot
U.S. Sen. Chuck Grassley (R-Iowa) wants to know if HHS will impose civil monetary penalties on drug companies that deny 340B pricing over multiple contract pharmacy.

Senate Finance Committee ranking Republican Chuck Grassley (Iowa) yesterday asked the U.S. Health and Human Services Department of Inspector General (OIG) if it plans to punish seven drug companies over their denials of 340B pricing when hospitals, health centers, and

Read More »

Sen. Manchin Endorses 340B Ally McKinley in Tight GOP Primary Race

Sen. Joe Manchin (D-WV) and Rep. David McKinley (R-WV) headshots
Conservative Democratic U.S. Sen. Joe Manchin has endorsed moderate Republican Rep. David McKinley in West Virginia's GOP congressional primary election next week against Rep. Alex Mooney, who is backed by ex-President Trump.

Conservative Democratic U.S. Sen. Joe Manchin (W.Va.) has endorsed and appeared in a campaign advertisement for Republican Rep. David McKinley (W.Va.), a moderate being challenged for re-election by a candidate endorsed by ex-President Donald Trump.

The GOP primary between McKinley

Read More »

With Retired Sen. Hatch’s Passing, a Legendary 340B Tale is Told

Sen. Orrin Hatch headshot
Retired U.S. Sen. Orrin Hatch (R-Utah), who died this weekend, played a key role in 340B's creation and development.

Retired U.S. Sen. Orrin Hatch of Utah, a conservative Republican icon who helped create and shape the 340B drug pricing program, has died. He was 88.

Hatch personally was responsible for choosing one of the 340B program’s most important covered

Read More »

73 Groups Want Congress to Enact Major Drug Pricing Reforms by Memorial Day

Push for Lower Rx Prices organization wordmark
Seventy three organizations, under the banner Push for LowerRx Prices, launched a campaign to press Congress to pass comprehensive Democratic drug pricing legislation by Memorial Day.

More than 70 groups representing patients, healthcare professionals, consumers, retirees, employers, and unions launched a campaign this morning to get comprehensive Democratic drug pricing legislation signed into law by Memorial Day.

It is premature to guess how the final version

Read More »

48 Hospitals Seek Readmission to 340B After Losing Eligibility Due to COVID-19 Pandemic

health care workers in hazmat suits with COVID-19 patient
Forty eight hospitals that lost their eligibility for 340B drug discounts for reasons related to the COVID-19 pandemic are seeking reinstatement to the 340B program.

At least 48 hospitals lost their eligibility for 340B drug discounts for reasons related to the COVID-19 pandemic and are seeking reinstatement to the 340B program, the U.S. Health Resources and Services Administration (HRSA) said this week.

April 14

Read More »

Harvard Drug Policy Experts Write in JAMA About How Congress Could Fix 340B Contract Pharmacy Mess

screenshot of 340B drug pricing program article in JAMA
"Contract pharmacy restrictions are the latest problem with implementation of the 340B program that threaten to undermine its laudable goals," three Harvard drug policy experts say in an opinion article in JAMA.

A nationally prominent drug policy expert and two colleagues at Harvard Medical School have written in JAMA how Congress could end the fight over 340B contract pharmacy and enhance 340B program integrity.

“First, Congress could explicitly allow the participation of

Read More »

Virginia Governor Signs 340B Anti-Discrimination Bill for Grantees

Gov. Glenn Youngkin signing legislation with supporters

Virginia Gov. Glenn Youngkin (R) yesterday signed legislation to stop insurers and their pharmacy benefit managers (PBMs) from discriminating against 340B grantee covered entities and their contract pharmacies. Hospitals are excluded from protection.

The new law takes effect July 1.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live